Cited 0 times in Scipus Cited Count

Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: an international collaborative meta-analysis.

DC Field Value Language
dc.contributor.authorKim, HS-
dc.contributor.authorSardi, JE-
dc.contributor.authorKatsumata, N-
dc.contributor.authorRyu, HS-
dc.contributor.authorNam, JH-
dc.contributor.authorChung, HH-
dc.contributor.authorPark, NH-
dc.contributor.authorSong, YS-
dc.contributor.authorBehtash, N-
dc.contributor.authorKamura, T-
dc.contributor.authorCai, HB-
dc.contributor.authorKim, JW-
dc.date.accessioned2014-05-29-
dc.date.available2014-05-29-
dc.date.issued2013-
dc.identifier.issn0748-7983-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/10231-
dc.description.abstractBACKGROUND: The efficacy of neoadjuvant chemotherapy before surgery (NCS) has not been well-established in FIGO stage IB1 to IIA cervical cancer when compared with primary surgical treatment (PST). Thus, we performed a meta-analysis to determine the efficacy of NCS in patients with FIGO stage IB1 to IIA cervical cancer when compared with PST.



METHODS: We searched Pubmed, Embase and the Cochrane Library between January 1987 and September 2010. Since there was a relative lack of relevant randomized controlled trials (RCTs), we included 5 RCTs and 4 observational studies involving 1784 patients among 523 potentially relevant studies.



RESULTS: NCS was related with lower rates of large tumor size (≥4 cm) (ORs, 0.22 and 0.10; 95% CI, 0.13-0.39 and 0.02-0.37) and lymph node metastasis (ORs, 0.61 and 0.38; 95% CI, 0.37-0.99 and 0.20-0.73) than PST in all studies and RCTs. Furthermore, NCS reduced the need of adjuvant radiotherapy (RT) in all studies (OR, 0.57; 95% CI, 0.33-0.98), and distant metastasis in all studies and RCTs (ORs, 0.61 and 0.61; 95% CI, 0.42-0.89 and 0.38-0.97). However, overall and loco-regional recurrences and progression-free survival were not different between the 2 treatments. On the other hand, NCS was associated with poorer overall survival in observational studies when compared with PST (HR, 1.68; 95% CI, 1.12-2.53).



CONCLUSIONS: Although NCS reduced the need of adjuvant RT by decreasing tumor size and lymph node metastasis, and distant metastasis, it failed to improve survival when compared with PST in patients with FIGO stage IB1 to IIA cervical cancer.
-
dc.language.isoen-
dc.subject.MESHAntineoplastic Combined Chemotherapy Protocols-
dc.subject.MESHChemotherapy, Adjuvant-
dc.subject.MESHDisease-Free Survival-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHHysterectomy-
dc.subject.MESHInternational Cooperation-
dc.subject.MESHLymphatic Metastasis-
dc.subject.MESHNeoadjuvant Therapy-
dc.subject.MESHNeoplasm Recurrence, Local-
dc.subject.MESHNeoplasm Staging-
dc.subject.MESHObservation-
dc.subject.MESHOdds Ratio-
dc.subject.MESHRadiotherapy, Adjuvant-
dc.subject.MESHRandomized Controlled Trials as Topic-
dc.subject.MESHResearch Design-
dc.subject.MESHRisk Factors-
dc.subject.MESHTreatment Outcome-
dc.subject.MESHUterine Cervical Neoplasms-
dc.titleEfficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: an international collaborative meta-analysis.-
dc.typeArticle-
dc.identifier.pmid23084091-
dc.identifier.urlhttp://linkinghub.elsevier.com/retrieve/pii/S0748-7983(12)01266-8-
dc.contributor.affiliatedAuthor유, 희석-
dc.type.localJournal Papers-
dc.identifier.doi10.1016/j.ejso.2012.09.003-
dc.citation.titleEuropean journal of surgical oncology-
dc.citation.volume39-
dc.citation.number2-
dc.citation.date2013-
dc.citation.startPage115-
dc.citation.endPage124-
dc.identifier.bibliographicCitationEuropean journal of surgical oncology, 39(2). : 115-124, 2013-
dc.identifier.eissn1532-2157-
dc.relation.journalidJ007487983-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Obstetrics & Gynecology
Files in This Item:
There are no files associated with this item.

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse